MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2022.08.018

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022

A national assessment of one-year heart outcomes after the 2018 adult heart allocation change.

Bradbrook Keighly, Goff Rebecca R, Lindblad Kelsi, Daly Richard C, Hall Shelley

ОбзорСтатьяПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

PURPOSE: On 10/18/2018 the Organ Procurement and Transplantation Network (OPTN) implemented modifications to adult heart allocation to better stratify the most medically urgent candidates by WL mortality. This paper reviews two years of post-policy monitoring with focus on post-transplant outcomes, especially for recipients with MCSDs.

METHODS

Cohorts of WL additions and recipients pre (10/18/16-10/17/18) and post (10/18/18-10/17/20) policy implementation were compared using the OPTN database. Competing risks analyses of waitlist mortality and Kaplan-Meier one-year post-transplant survival were performed by medical urgency statuses and policy era. Similar analyses were performed for subsets of candidates and recipients on devices.

RESULTS

Pre-implementation status 1A candidates had the highest cumulative incidence of removal from the waitlist due to death or too sick to transplant and the highest cumulative incidence of transplant, followed by statuses 1B and 2. Median time to transplant decreased from 226 to 85 days for those transplanted. There was no difference in one-year patient survival (pre=91.3% [90.2, 92.4]; post=91.8% [90.8, 92.9]; p=0.44) overall, or for recipients transplanted with an LVAD (pre=91.7% [90.1, 93.2]; post=91.4% [89.7, 93.2]; p=0.85) or IABP (pre=91.7% [88.1, 95.4]; post=92.1% [90.1, 94.0]; p=0.92).

CONCLUSION

The policy improved stratification of the most medically urgent candidates according to risk of death on the WL with decreased median wait times, higher transplant rates and no observed adverse effect on 1-year patient survival. No adverse effects for candidates listed or transplanted on IABP, ECMO, or LVAD were observed.

Для цитирования: Bradbrook Keighly, Goff Rebecca R, Lindblad Kelsi, Daly Richard C, Hall Shelley. A national assessment of one-year heart outcomes after the 2018 adult heart allocation change.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022. DOI: 10.1016/j.healun.2022.08.018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.